Phase I-IIa Clinical Development Solutions
Navigate complex early development with confidence.
Discover the Worldwide Difference
The success of an early phase program depends on making the right decisions at the right time. Worldwide partners with sponsors to provide the responsiveness, collaboration, and scientific insight needed to move programs forward with confidence.
From initial planning through study completion, we are committed to transparent communication, proactive problem-solving, and delivering quality results that help inform the next stage of development.
We help sponsors reduce complexity, accelerate learning, and make better-informed development decisions at every milestone.
Supporting Sponsors Through Critical Early Development Milestones
Early phase development requires specialized expertise, thoughtful execution, and the ability to navigate complex study designs. Worldwide supports sponsors from first-in-human through Phase IIa. Leveraging deep therapeutic and modality expertise, along with our preferred global site network, we help execute complex protocols that inform key development decisions.
-
-
Phase I-IIa trial execution
-
-
Healthy volunteer, inpatient, and patient-based studies
-
-
First-in-human, dose escalation, and dose optimization studies
-
-
Clinical pharmacology studies
-
-
Therapeutic and modality expertise across complex protocol
We’re here to help you succeed
A Tailored Program, Every Time
We understand that no two Phase I trials are the same. That’s why we offer flexible, customized solutions through our extensive site network. With an unwavering commitment to excellence, we deliver high-quality data faster, ensuring your asset progresses seamlessly to the next phase without compromise.
